buy on the dip?

Discussion in 'Valeant Pharmaceuticals' started by Anonymous, Aug 18, 2014 at 4:23 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Over the last 12 days, we gotten very oversold,” Stockton said. “That, of course, yielded a short-term low. Even if we see a retest next week on geopolitical concerns – which is certainly a possibility with the lack of volume we’ve seen in the marketplace and the resulting skittishness – I would be buying into weakness.
     

  2. Anonymous

    Anonymous Guest

    Not dipping now. $120 and counting